Author | Ranjana Advani, MD | OncLive

Author | Ranjana Advani, MD

Articles

Dr. Advani Discusses Front-Line Brentuximab

May 06, 2013

Video

Ranjana Advani, MD, Professor of Medicine and Oncology, Stanford University, discusses the movement of brentuximab vedotin combined with CHOP to the front-line.

Dr. Advani Discusses CD30 as a Target in ALCL

April 18, 2013

Video

Ranjana Advani, MD, Professor of Medicine and Oncology, Stanford University, discusses targeting CD30 as a target and the use of brentuximab vedotin in anaplastic large-cell lymphoma.

Dr. Advani on EPOCH-R in B Cell Lymphoma

March 27, 2013

Video

Ranjana Advani, MD, Professor of Medicine and Oncology, Stanford University, details the difference between EPOCH-R and R-CHOP chemotherapy.

Dr. Advani Discusses Outcomes in ALCL

March 11, 2013

Video

Ranjana Advani, MD, Professor of Medicine and Oncology, Stanford University, discusses outcomes for patients with anaplastic large-cell lymphoma.

x